38390431|t|Different reactive profiles of calmodulin in the CSF samples of Chinese patients of four types of genetic prion diseases.
38390431|a|Background and purpose: Calmodulin (CaM) levels exhibit significant elevation in the brain tissue of rodent and cell line models infected with prion, as well as in the cerebrospinal fluid (CSF) samples from patients diagnosed with sporadic Creutzfeldt-Jakob disease (sCJD). However, the status of CSF CaM in patients with genetic prion diseases (gPrDs) remains unclear. This study aims to assess the characteristics of CSF CaM in Chinese patients presenting four subtypes of gPrDs. Methods: A total of 103 CSF samples from patients diagnosed with T188K-gCJD, E200K-gCJD, D178N-FFI, P102L-GSS were included in this study, along with 40 CSF samples from patients with non-prion diseases (non-PrDs). The presence of CSF CaM and 14-3-3 proteins was assessed using Western blots analysis, while levels of CSF 14-3-3 and total tau were measured using enzyme-linked immunosorbent assays (ELISAs). Statistical methods including multivariate logistic regression were employed to evaluate the association between CSF CaM positivity and relevant clinical, laboratory, and genetic factors. Results: The positive rates of CSF CaM were significantly higher in cases of T188K-gCJD (77.1%), E200K-gCJD (86.0%), and P102-GSS (90.9%) compared to non-PrD cases (22.5%). In contrast, CSF CaM positivity was slightly elevated in D178N-FFI (34.3%). CSF CaM positivity was remarkably high in patients who tested positive for CSF 14-3-3 by Western blot and exhibited high levels of total tau (>=1400 pg/ml) as measures by ELISA. Multivariate logistic regression analysis confirmed a significant association between CSF CaM positivity and specific mutations in PRNP, as well as with CSF 14-3-3 positivity. Furthermore, the diagnostic performance of CaM surpassed that of 14-3-3 and tau when analyzing CSF samples from T188K-gCJD and E200K-gCJD patients. Conclusion: Western blot analysis reveals significant variations in the positivity of CSF CaM among the four genotypes of gPrD cases, demonstrating a positive correlation with 14-3-3 positivity and elevated tau levels in CSF.
38390431	31	41	calmodulin	Gene	801
38390431	72	80	patients	Species	9606
38390431	98	120	genetic prion diseases	Disease	MESH:D017096
38390431	146	156	Calmodulin	Gene	801
38390431	158	161	CaM	Gene	801
38390431	265	270	prion	Disease	MESH:D017096
38390431	329	337	patients	Species	9606
38390431	353	387	sporadic Creutzfeldt-Jakob disease	Disease	MESH:C565143
38390431	389	393	sCJD	Disease	MESH:C565143
38390431	423	426	CaM	Gene	801
38390431	430	438	patients	Species	9606
38390431	444	466	genetic prion diseases	Disease	MESH:D017096
38390431	468	473	gPrDs	Disease	MESH:D017096
38390431	545	548	CaM	Gene	801
38390431	560	568	patients	Species	9606
38390431	597	602	gPrDs	Disease	MESH:D017096
38390431	645	653	patients	Species	9606
38390431	669	674	T188K	ProteinMutation	tmVar:p|SUB|T|188|K;HGVS:p.T188K;VariantGroup:3;CorrespondingGene:4137;CorrespondingSpecies:9606
38390431	675	679	gCJD	Disease	
38390431	681	686	E200K	ProteinMutation	tmVar:p|SUB|E|200|K;HGVS:p.E200K;VariantGroup:0;CorrespondingGene:4137;RS#:1185623355;CorrespondingSpecies:9606
38390431	687	691	gCJD	Disease	
38390431	693	698	D178N	ProteinMutation	tmVar:p|SUB|D|178|N;HGVS:p.D178N;VariantGroup:1;CorrespondingGene:5621;RS#:74315403;CorrespondingSpecies:9606;CA#:261110
38390431	704	709	P102L	ProteinMutation	tmVar:p|SUB|P|102|L;HGVS:p.P102L;VariantGroup:2;CorrespondingGene:5621;RS#:74315401;CorrespondingSpecies:9606;CA#:256774
38390431	710	713	GSS	Disease	MESH:D016098
38390431	774	782	patients	Species	9606
38390431	792	806	prion diseases	Disease	MESH:D017096
38390431	812	816	PrDs	Disease	
38390431	839	842	CaM	Gene	801
38390431	847	853	14-3-3	Gene	10971
38390431	926	932	14-3-3	Gene	10971
38390431	943	946	tau	Gene	4137
38390431	1129	1132	CaM	Gene	801
38390431	1235	1238	CaM	Gene	801
38390431	1277	1282	T188K	ProteinMutation	tmVar:p|SUB|T|188|K;HGVS:p.T188K;VariantGroup:3;CorrespondingGene:4137;CorrespondingSpecies:9606
38390431	1283	1287	gCJD	Disease	
38390431	1297	1302	E200K	ProteinMutation	tmVar:p|SUB|E|200|K;HGVS:p.E200K;VariantGroup:0;CorrespondingGene:4137;RS#:1185623355;CorrespondingSpecies:9606
38390431	1303	1307	gCJD	Disease	
38390431	1326	1329	GSS	Disease	MESH:D016098
38390431	1354	1357	PrD	Disease	
38390431	1390	1393	CaM	Gene	801
38390431	1430	1435	D178N	ProteinMutation	tmVar:p|SUB|D|178|N;HGVS:p.D178N;VariantGroup:1;CorrespondingGene:5621;RS#:74315403;CorrespondingSpecies:9606;CA#:261110
38390431	1453	1456	CaM	Gene	801
38390431	1491	1499	patients	Species	9606
38390431	1528	1534	14-3-3	Gene	10971
38390431	1586	1589	tau	Gene	4137
38390431	1717	1720	CaM	Gene	801
38390431	1758	1762	PRNP	Gene	5621
38390431	1784	1790	14-3-3	Gene	10971
38390431	1846	1849	CaM	Gene	801
38390431	1868	1874	14-3-3	Gene	10971
38390431	1879	1882	tau	Gene	4137
38390431	1915	1920	T188K	ProteinMutation	tmVar:p|SUB|T|188|K;HGVS:p.T188K;VariantGroup:3;CorrespondingGene:4137;CorrespondingSpecies:9606
38390431	1921	1925	gCJD	Disease	
38390431	1930	1935	E200K	ProteinMutation	tmVar:p|SUB|E|200|K;HGVS:p.E200K;VariantGroup:0;CorrespondingGene:4137;RS#:1185623355;CorrespondingSpecies:9606
38390431	1936	1940	gCJD	Disease	
38390431	1941	1949	patients	Species	9606
38390431	2041	2044	CaM	Gene	801
38390431	2073	2077	gPrD	Disease	
38390431	2127	2133	14-3-3	Gene	10971
38390431	2158	2161	tau	Gene	4137
38390431	Association	MESH:D016098	RS#:74315401;HGVS:p.P102L;CorrespondingGene:5621
38390431	Positive_Correlation	MESH:C565143	801
38390431	Association	10971	801
38390431	Association	5621	801
38390431	Positive_Correlation	MESH:D017096	801
38390431	Positive_Correlation	4137	801
38390431	Positive_Correlation	MESH:D016098	801
38390431	Association	MESH:D016098	5621

